Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOctopus T.vct Regulatory News (OTV2)

Share Price Information for Octopus T.vct (OTV2)

Share Price is delayed by 15 minutes
Get Live Data
18.50    0.00 (0.00%)
Bid:
17.00
Ask:
20.00
Spread: 3.00 (17.647%)
Market Cap: £304.92m
OTV2 Live PriceLast checked at - London Stock Exchange

Intraday Octopus T.vct Share Chart

Director Appointment

27 Jul 2023 10:00

Director Appointment

Octopus Titan VCT plc

Director Appointment

Octopus Titan VCT plc (the β€˜Company’) is delighted to announce the appointment of Julie Nahid Rahman as an independent non-executive director with effect from 1 August 2023.

Julie is currently an external advisor to McKinsey’s life sciences practice in addition to her own independent consulting. She brings over 20 years of experience across a diverse mix of industries from top tier global firms including private equity, executive search and strategy consulting. Julie was previously a member of the European healthcare practice at Spencer Stuart leading senior executive and board appointments for life sciences companies and healthcare funds. Prior to executive search, she spent a decade as an investor at Visium Healthcare Partners and Paul Capital Healthcare providing creative growth capital to life sciences companies. Julie began her career as a strategy consultant with Bain & Company advising healthcare and private equity clients.

Julie holds an M.B.A. from Harvard Business School and graduated from the Massachusetts Institute of Technology with her M.Sc. in materials science (MIT Langer Lab) and her B.Sc. in chemical engineering.

Tom Leader, Chair of Octopus Titan VCT plc said:β€œWe are delighted to welcome Julie and know she will make a great contribution to the Board. We look forward to benefitting from her wealth of experience in the sector.”

Julie will be a member of the Audit Committee, Management Engagement Committee and Nomination & Remuneration Committee of the Company, with effect from the date of her appointment.

There is no additional information required to be disclosed pursuant to Listing Rule 9.6.13 in relation to this appointment.

For further information please contact:

Rachel PeatOctopus Company Secretarial Services Limited Tel: +44 (0)80 0316 2067

LEI: 213800A67IKGG6PVYW75

Date   Source Headline
1st Jul 20267:00 amGNWTotal Voting Rights and Capital
18th Jun 20266:15 pmGNWResults of Annual General Meeting
18th Jun 20266:15 pmBUSResults of Annual General Meeting
3rd Jun 202610:15 amGNWAdmission of Further Securities to Trading
3rd Jun 202610:15 amBUSAdmission of Further Securities to Trading
1st Jun 20267:00 amGNWTotal Voting Rights and Capital
1st Jun 20267:00 amBUSTotal Voting Rights and Capital
14th May 20268:40 amGNWIssue of Equity and Total Voting Rights
14th May 20268:40 amBUSIssue of Equity and Total Voting Rights
8th May 20264:30 pmGNWAnnual Report for the year ended 31 December 2025 and Notice of Meeting
8th May 20264:30 pmBUSAnnual Report for the year ended 31 December 2025 and Notice of Meeting
1st May 20267:00 amGNWTotal Voting Rights and Capital
1st May 20267:00 amBUSTotal Voting Rights and Capital
29th Apr 20267:00 amGNWAnnual report and financial statements for the year ended 31 December 2025
29th Apr 20267:00 amBUSAnnual report and financial statements for the year ended 31 December 2025
1st Apr 20267:00 amGNWTotal Voting Rights and Capital
1st Apr 20267:00 amBUSTotal Voting Rights and Capital
16th Mar 20267:00 amGNWNet Asset Value(s)
16th Mar 20267:00 amBUSNet Asset Value(s)
2nd Mar 20267:00 amGNWTotal Voting Rights and Capital
2nd Mar 20267:00 amBUSTotal Voting Rights and Capital
2nd Feb 20267:00 amGNWTotal Voting Rights and Capital
2nd Jan 20267:00 amRNSTotal Voting Rights and Capital
2nd Jan 20267:00 amGNWTotal Voting Rights and Capital
17th Dec 20254:00 pmGNWUpdate Statement on 2025 Annual General Meeting Voting Results
5th Dec 20254:00 pmGNWBoard Change
4th Dec 20254:30 pmGNWDirectorate change
1st Dec 20257:00 amGNWTotal Voting Rights and Capital
3rd Nov 20257:00 amGNWTotal Voting Rights and Capital
14th Oct 20254:15 pmGNWResult of General Meeting
1st Oct 20257:00 amGNWTotal Voting Rights and Capital
26th Sep 20257:00 amGNWHalf-Yearly Report
1st Sep 20257:00 amGNWTotal Voting Rights and Capital
1st Aug 20257:00 amGNWTotal Voting Rights and Capital
30th Jul 20259:00 amGNWUpdate on Strategic Review
1st Jul 20257:00 amGNWTotal Voting Rights and Capital
19th Jun 20255:30 pmGNWResults of Annual General Meeting
3rd Jun 20255:00 pmGNWTotal Voting Rights and Capital
30th May 20253:50 pmGNWIssue of Equity and Total Voting Rights
12th May 202512:15 pmGNWAnnual Report for the year ended 31 December 2024 and Notice of Meeting
1st May 20257:00 amGNWTotal Voting Rights and Capital
29th Apr 20257:00 amGNWAnnual report and financial statements for the year ended 31 December 2024
1st Apr 20257:00 amGNWTotal Voting Rights and Capital
19th Mar 20258:30 amGNWNet Asset Value, Review Update and Dividend Declaration
3rd Mar 20257:00 amGNWTotal Voting Rights and Capital
3rd Feb 20257:00 amGNWTotal Voting Rights and Capital
2nd Jan 20257:00 amGNWTotal Voting Rights and Capital
2nd Dec 20247:00 amGNWTotal Voting Rights and Capital
1st Nov 20247:00 amGNWTotal Voting Rights and Capital
24th Oct 20244:30 pmGNWPurchase of Own Securities and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.